Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
US-Listed Public Company Profile built from SEC and market records · June 2026

BECTON DICKINSON & CO (BDX)

$196.39 -1.27% NYSE: BDX · 15-min delayed
  • FRANKLIN LAKES, New Jersey
  • Public · NYSE: BDX
  • 72,000 employees
$43.1BMarket cap
$21.8BRevenue · FY2025
$1.7BNet income
72,000Employees
BDXNYSE
1963IPO

About BECTON DICKINSON & CO

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$21.8B
Net income
$1.7B
Total assets
$55.3B
Market cap
$43.1B

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: BDX
$196.39 -1.27%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$140.71 $210.02

52-week range

Market cap
$43.1B
Dividend yield
2.14%
Shares outstanding
219.4M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Sep 25, 1963

Becton Dickinson & Co (BDX) Stock Price

  • Profitable — net income of $1.7B in FY2025.
  • Trading 6% below its 52-week high.
  • Pays a dividend yielding about 2.14% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review BECTON DICKINSON & CO.

Write a review
Newsroom

News about BECTON DICKINSON & CO

News & sentiment via Polygon.io

FAQ

Becton Dickinson & Co: frequently asked questions

Is Becton Dickinson & Co an American company?

Yes — Becton Dickinson & Co is an American company headquartered in Franklin Lakes, New Jersey. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.

Where is Becton Dickinson & Co headquartered?

Becton Dickinson & Co is headquartered in Franklin Lakes, New Jersey, United States.

Is Becton Dickinson & Co publicly traded?

Yes — Becton Dickinson & Co is a publicly traded company. Its stock trades under the ticker symbol BDX on the NYSE.

What does Becton Dickinson & Co do?

Becton Dickinson & Co is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →